Zweig Di Menna Associates LLC Abb Vie Inc. Transaction History

Zweig Di Menna Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 01, 2018	SELL	$89.78 - $106.23 $206,494 - $244,329	-2,300 Closed	0 $0
Q1 2018 May 07, 2018	SELL	$92.01 - $123.21 $9.24 Million - $12.4 Million	-100,474 Reduced 97.76%	2,300 $218,000
Q4 2017 Feb 12, 2018	BUY	$89.56 - $98.21 $9.2 Million - $10.1 Million	102,774	102,774 $9.94 Million

3,657

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $297B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Zweig Di Menna Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Zweig Di Menna Associates LLC with notifications on news.